Please provide your email address to receive an email when new articles are posted on . Due to nonspecific symptoms and a wide variety of therapeutic options, diagnosis and treatment of pulmonary ...
GREENVILLE, S.C. (WSPA)– On average, one American dies of a blood clot every 6 minutes, according to the Centers for Disease Control and Prevention. As part of our ask the expert series, in ...
The “triple aim” promised by healthcare reform—better-quality care, greater patient satisfaction, at a lower cost—will play out procedure by procedure as physicians find ways to deliver better ...
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. PE is a type of sexual dysfunction that affects up ...
Please provide your email address to receive an email when new articles are posted on . Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded ...
Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony(R) Thrombectomy System to treat pulmonary embolism (PE), a life-threatening condition ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
A pulmonary embolism (PE) occurs when blood flow to an artery that supplies blood to the lungs has become blocked, typically due to a blood clot. Complications can develop from either the clot or the ...
BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...
About 900,000 people are affected by pulmonary embolism (PE) each year in the United States, according to the American Lung Association and about 100,000 people die each year as a result of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results